166 related articles for article (PubMed ID: 25354935)
21. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes.
Boonyasrisawat W; Eberle D; Bacci S; Zhang YY; Nolan D; Gervino EV; Johnstone MT; Trischitta V; Shoelson SE; Doria A
Diabetes; 2007 Feb; 56(2):499-505. PubMed ID: 17259397
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in the tumour necrosis factor alpha-induced protein 3 (TNFAIP3) gene are associated with chronic rhinosinusitis.
Cormier C; Bossé Y; Mfuna L; Hudson TJ; Desrosiers M
J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):133-41. PubMed ID: 19344623
[TBL] [Abstract][Full Text] [Related]
24. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
Vashist YK; Effenberger KE; Vettorazzi E; Riethdorf S; Yekebas EF; Izbicki JR; Pantel K
Ann Surg; 2012 Jun; 255(6):1105-12. PubMed ID: 22580852
[TBL] [Abstract][Full Text] [Related]
25. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
26. The TNFAIP3 polymorphism rs610604 both associates with the risk of psoriasis vulgaris and affects the clinical severity.
Zhang C; Zhu KJ; Liu H; Quan C; Liu Z; Li SJ; Zhu CY; Li KS; Fan YM
Clin Exp Dermatol; 2015 Jun; 40(4):426-30. PubMed ID: 25496073
[TBL] [Abstract][Full Text] [Related]
27. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.
Vashist YK; Trump F; Gebauer F; Kutup A; Güngör C; Kalinin V; Muddasar R; Vettorazzi E; Yekebas EF; Brandt B; Pantel K; Izbicki JR
Target Oncol; 2014 Mar; 9(1):43-52. PubMed ID: 23377570
[TBL] [Abstract][Full Text] [Related]
28. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Wu X; Gu J; Wu TT; Swisher SG; Liao Z; Correa AM; Liu J; Etzel CJ; Amos CI; Huang M; Chiang SS; Milas L; Hittelman WN; Ajani JA
J Clin Oncol; 2006 Aug; 24(23):3789-98. PubMed ID: 16785472
[TBL] [Abstract][Full Text] [Related]
29. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
[TBL] [Abstract][Full Text] [Related]
30. Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagus.
Ghadban T; Miro JT; Trump F; Tsui TY; Uzunoglu FG; Reeh M; Gebauer F; Bachmann K; Wellner U; Kalinin V; Pantel K; Izbicki JR; Vashist YK
Clin Genet; 2016 Oct; 90(4):343-50. PubMed ID: 26916598
[TBL] [Abstract][Full Text] [Related]
31. Expression of the autoimmunity associated TNFAIP3 is increased in rheumatoid arthritis but does not differ according to genotype at 6q23.
Maxwell JR; Gowers IR; Kuet KP; Barton A; Worthington J; Wilson AG
Rheumatology (Oxford); 2012 Aug; 51(8):1514-5. PubMed ID: 22623711
[No Abstract] [Full Text] [Related]
32. Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.
Motoyama S; Mori K; Kamei T; Miura M; Hinai Y; Sato Y; Yoshino K; Sasaki T; Miyata G; Seto Y; Ogawa J
Ann Surg Oncol; 2013 Jun; 20(6):1978-84. PubMed ID: 23212764
[TBL] [Abstract][Full Text] [Related]
33. The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx.
Lehnerdt GF; Franz P; Winterhoff S; Bankfalvi A; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
Laryngoscope; 2008 Dec; 118(12):2172-6. PubMed ID: 19029852
[TBL] [Abstract][Full Text] [Related]
34. TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils.
Indhumathi S; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Negi VS
Br J Biomed Sci; 2015; 72(4):168-73. PubMed ID: 26738398
[TBL] [Abstract][Full Text] [Related]
35. Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
Vashist YK; Uzunoglu G; Deutsch L; Kalinin V; Zehler O; Alzadjali A; Kutup A; Izbicki JR; Yekebas EF
J Surg Res; 2011 Apr; 166(2):e121-7. PubMed ID: 21236443
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist YK; Blessmann M; Trump F; Kalinin V; Kutup A; Schneider C; Gawad K; Kaifi JT; Schmelzle R; Izbicki JR; Yekebas EF
J Oral Pathol Med; 2008 Sep; 37(8):480-4. PubMed ID: 18312299
[TBL] [Abstract][Full Text] [Related]
37. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
[TBL] [Abstract][Full Text] [Related]
38. XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.
Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
Anticancer Res; 2014 Jun; 34(6):3031-7. PubMed ID: 24922669
[TBL] [Abstract][Full Text] [Related]
39. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
40. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
